Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy
- PMID: 12183033
- DOI: 10.1016/s0304-3940(02)00684-5
Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy
Abstract
Adenosine is known to suppress seizure activity mainly by activation of adenosine A(1) receptors. However, little is known about the potential involvement of other types of adenosine receptors in seizure suppression. It was now tested whether activation of adenosine A(2A) receptors would be effective in the suppression of generalized brainstem seizures. Genetically epilepsy-prone rats were intraperitoneally injected with increasing doses of the A(2A) receptor agonist, 5'-(N-cyclopropyl)-carboxamido-adenosine (CPCA), and, for comparison, with the A(1) receptor agonist, 2-chloro-N(6)-cyclopentyladenosine (CCPA). Both CPCA and CCPA were effective in suppressing generalized brainstem seizures with minimal effective concentrations of 2.5 and 1.5 mg/kg, respectively. Seizure suppression was maintained when CPCA was co-injected with the peripherally acting adenosine receptor antagonist 8-(p-sulphophenyl)theophylline, suggesting that central activation of A(2A) receptors effectively contributes to seizure suppression.
Similar articles
-
Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy.Epilepsia. 2003 Jul;44(7):877-85. doi: 10.1046/j.1528-1157.2003.03603.x. Epilepsia. 2003. PMID: 12823569
-
Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.Eur J Pharmacol. 1999 Apr 29;371(2-3):137-45. doi: 10.1016/s0014-2999(99)00132-6. Eur J Pharmacol. 1999. PMID: 10357250
-
Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.Eur J Pharmacol. 1995 Dec 29;294(2-3):383-9. doi: 10.1016/0014-2999(95)00557-9. Eur J Pharmacol. 1995. PMID: 8750698
-
Adenosine receptors as targets for drug development.Drug News Perspect. 2003 Jun;16(5):283-9. doi: 10.1358/dnp.2003.16.5.829316. Drug News Perspect. 2003. PMID: 12942159 Review.
-
Adenosine receptors and epilepsy: current evidence and future potential.Int Rev Neurobiol. 2014;119:233-55. doi: 10.1016/B978-0-12-801022-8.00011-8. Int Rev Neurobiol. 2014. PMID: 25175969 Free PMC article. Review.
Cited by
-
Tuning and fine-tuning of synapses with adenosine.Curr Neuropharmacol. 2009 Sep;7(3):180-94. doi: 10.2174/157015909789152128. Curr Neuropharmacol. 2009. PMID: 20190960 Free PMC article.
-
The adenosine kinase hypothesis of epileptogenesis.Prog Neurobiol. 2008 Mar;84(3):249-62. doi: 10.1016/j.pneurobio.2007.12.002. Epub 2007 Dec 23. Prog Neurobiol. 2008. PMID: 18249058 Free PMC article. Review.
-
Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures.PLoS One. 2013 Jun 25;8(6):e67060. doi: 10.1371/journal.pone.0067060. Print 2013. PLoS One. 2013. PMID: 23825618 Free PMC article.
-
Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection.Br J Pharmacol. 2009 Sep;158(1):15-22. doi: 10.1111/j.1476-5381.2009.00157.x. Epub 2009 Jun 5. Br J Pharmacol. 2009. PMID: 19508402 Free PMC article. Review.
-
Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.Neuropharmacology. 2020 May 1;167:107741. doi: 10.1016/j.neuropharm.2019.107741. Epub 2019 Aug 13. Neuropharmacology. 2020. PMID: 31419398 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
